Recent Company News

• 05:09 AM ET Sep 04, 2025
  

  bioMerieux downgraded to accumulate from buy at Gilbert Dupont (timing uncertain) (€118.20, +0.30)

• 04:21 AM ET Aug 26, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:08 AM ET Sep 04, 2025
  

  Quick Take - bioMerieux reports mixed set of results; FY25 EBIT guidance upgraded, while sales consensus adjusted lower (€115.80, -2.10)

• 02:56 AM ET Sep 04, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:23 AM ET Sep 04, 2025
  

  bioMerieux reports H1 net income €161M vs FactSet €249.3M [2 est, €249-249.6M]. Adjusts FY guidance (€117.90, 0.00)

• 12:33 AM ET Aug 27, 2025
  

  JPMorgan initiates BIM.FP, DIA.IM

• 12:55 AM ET Aug 26, 2025
  

  Morgan Stanley upgrades DIA.IM; downgrades BIM.FP

• 04:05 AM ET Aug 21, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (61 total)

• 12:02 PM ET Aug 18, 2025
  

  bioMerieux receives U.S. 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens (€127.20, 0.00)